Who should not take a GLP-1 medication?
GLP-1 receptor agonists are prescription-only medicines and are not suitable for everyone. Key groups who are generally advised against using them include people with a personal or family history of medullary thyroid carcinoma (MTC), those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), individuals with a known hypersensitivity to the active substance, and those who are pregnant or breastfeeding. Several other medical conditions require careful clinical evaluation before a GLP-1 medication can be considered. Because suitability depends on individual medical history, a qualified clinician or doctor should always make the final decision.
Established contraindications
Prescribing information for GLP-1 receptor agonists consistently lists the following as contraindications — meaning the medication should generally not be used at all:
- Medullary thyroid carcinoma (MTC): A personal or family history of MTC is a contraindication. In preclinical rodent studies, some GLP-1 receptor agonists were associated with thyroid C-cell tumours, though the relevance to humans remains uncertain.
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2): This genetic condition increases the risk of MTC, so GLP-1 receptor agonists are contraindicated.
- Known hypersensitivity: Anyone who has had a serious allergic reaction (such as anaphylaxis or angioedema) to a specific GLP-1 receptor agonist or any of its excipients should not use that medication.
Conditions requiring particular caution
Some conditions do not absolutely prohibit use but require careful risk–benefit assessment by a prescriber:
- History of pancreatitis: GLP-1 receptor agonists have been associated with reports of acute pancreatitis. Individuals with a history of pancreatitis are typically treated with caution, and the medication is usually discontinued if pancreatitis is suspected.
- Severe gastrointestinal disease: Conditions such as gastroparesis or inflammatory bowel disease may be worsened by the gastrointestinal effects of GLP-1 receptor agonists. Clinical judgement is essential.
- Diabetic retinopathy: In some cases, rapid improvements in blood glucose control have been linked to a temporary worsening of diabetic retinopathy. Patients with existing retinopathy may need closer monitoring.
- Severe renal or hepatic impairment: The degree of caution varies between individual medicines, so a doctor will assess kidney and liver function before prescribing.
- Type 1 diabetes: GLP-1 receptor agonists are not licensed for type 1 diabetes and should not be used as a substitute for insulin in insulin-dependent patients.
Pregnancy, breastfeeding, and younger age groups
GLP-1 receptor agonists are generally contraindicated during pregnancy due to insufficient safety data, and women of childbearing potential are usually advised to use effective contraception during treatment. Breastfeeding is similarly not recommended while taking these medications. Prescribing in children and adolescents is limited to specific licensed indications and age groups, and only under specialist supervision. Individual circumstances should always be discussed with a qualified clinician.
Why suitability is always a clinical decision
Published contraindications provide a general framework, but every patient's medical history, concurrent medications, and personal risk factors are different. Drug interactions, the presence of multiple comorbidities, and planned surgical procedures are among the many factors a prescriber will weigh. No online resource — including this educational page from the GLP121 Protocol Library — can replace that individualised clinical assessment. If you are unsure whether a GLP-1 medication is appropriate for you, speak with your doctor.
FAQ
Q: Can I take a GLP-1 medication if I have a thyroid condition? A: It depends on the specific thyroid condition. A personal or family history of medullary thyroid carcinoma or MEN 2 is a contraindication. Other thyroid conditions, such as hypothyroidism managed with thyroid hormone replacement, may not preclude use, but this is a decision for your prescribing clinician.
Q: Are GLP-1 medications safe to use alongside other diabetes treatments? A: GLP-1 receptor agonists are sometimes prescribed alongside other glucose-lowering therapies, but combinations can increase the risk of certain side effects, including hypoglycaemia when used with insulin or sulphonylureas. A doctor will adjust treatment plans and monitoring accordingly.
Q: What should I do if I think I have a contraindication but am already taking a GLP-1 medication? A: Do not stop or change any prescribed medication without consulting your doctor. Contact your prescriber or healthcare team to discuss your concerns so they can review your treatment safely.